A small risk with intravenous formulations is allergic reactions, ranging from flushing, itching, swelling of the lips and throat to difficulty breathing and low blood pressure ( 23 )
P 0.01 was considered statistically significant
A groundbreaking study by Mayo Clinic has revealed that genetic testing can predict which patients are most likely to experience nausea when taking GLP-1 agonist medications such as Wegovy and Zepbound
Over time, significant improvements in blood sugar control and weight management are often observed, contributing to better overall health and reduced diabetes complications
Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 d
Until the FDA formally updates the Category 2 list, the legal status of these peptides for compounding remains technically unchanged